Michael Lynn Fisher, DO | |
150 7th Ave Ste 200, Chardon, OH 44024-2909 | |
(440) 285-4999 | |
(440) 285-5870 |
Full Name | Michael Lynn Fisher |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 10 Years |
Location | 150 7th Ave Ste 200, Chardon, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295150209 | NPI | - | NPPES |
0408845 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 000000 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Hospital Home Care Services, Inc | Warrensville hts, OH | Home health agency |
Uh Regional Hospitals | Richmond heights, OH | Hospital |
Lake Health | Concord, OH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Beacon Orthopaedics And Sports Medicine Ltd | 0345136412 | 438 |
News Archive
Siemens Healthineers announced today it is significantly expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic. Recognizing the critical need for accurate diagnostic testing to manage COVID-19, the company has developed a laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 antibodies in blood.
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast cancer.
Even a slow economy can't stop healthcare costs from rising. A new report by the Kaiser Family Foundation and the Health Research & Educational Trust shows that the cost of employer-provided insurance rose 9% this year -; even as workers and their families were cutting back on trips to the doctor's office -; and has more than doubled over the last decade.
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
› Verified 7 days ago
Entity Name | University Primary Care Practices Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
Siemens Healthineers announced today it is significantly expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic. Recognizing the critical need for accurate diagnostic testing to manage COVID-19, the company has developed a laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 antibodies in blood.
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast cancer.
Even a slow economy can't stop healthcare costs from rising. A new report by the Kaiser Family Foundation and the Health Research & Educational Trust shows that the cost of employer-provided insurance rose 9% this year -; even as workers and their families were cutting back on trips to the doctor's office -; and has more than doubled over the last decade.
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
› Verified 7 days ago
Entity Name | Beacon Orthopaedics & Sports Medicine Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1386670065 PECOS PAC ID: 0345136412 Enrollment ID: O20040225000690 |
News Archive
Siemens Healthineers announced today it is significantly expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic. Recognizing the critical need for accurate diagnostic testing to manage COVID-19, the company has developed a laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 antibodies in blood.
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast cancer.
Even a slow economy can't stop healthcare costs from rising. A new report by the Kaiser Family Foundation and the Health Research & Educational Trust shows that the cost of employer-provided insurance rose 9% this year -; even as workers and their families were cutting back on trips to the doctor's office -; and has more than doubled over the last decade.
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
› Verified 7 days ago
Entity Name | Precision Orthopaedic Specialties, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649257973 PECOS PAC ID: 4880678325 Enrollment ID: O20040614001294 |
News Archive
Siemens Healthineers announced today it is significantly expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic. Recognizing the critical need for accurate diagnostic testing to manage COVID-19, the company has developed a laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 antibodies in blood.
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast cancer.
Even a slow economy can't stop healthcare costs from rising. A new report by the Kaiser Family Foundation and the Health Research & Educational Trust shows that the cost of employer-provided insurance rose 9% this year -; even as workers and their families were cutting back on trips to the doctor's office -; and has more than doubled over the last decade.
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Lynn Fisher, DO 6480 Harrison Ave Ste 201, Cincinnati, OH 45247-7961 Ph: (513) 713-1779 | Michael Lynn Fisher, DO 150 7th Ave Ste 200, Chardon, OH 44024-2909 Ph: (440) 285-4999 |
News Archive
Siemens Healthineers announced today it is significantly expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic. Recognizing the critical need for accurate diagnostic testing to manage COVID-19, the company has developed a laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 antibodies in blood.
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast cancer.
Even a slow economy can't stop healthcare costs from rising. A new report by the Kaiser Family Foundation and the Health Research & Educational Trust shows that the cost of employer-provided insurance rose 9% this year -; even as workers and their families were cutting back on trips to the doctor's office -; and has more than doubled over the last decade.
OrbusNeich announced that clinical data presented at the Joint Intervention Meeting (JIM) 2010 in Rome provide further evidence that the company's Genous stent could be a treatment of choice for patients not suitable for long term dual antiplatelet therapy. The investigator initiated, 50 patient, multicenter study evaluated the safety of patients receiving only 10 days dual antiplatelet therapy undergoing stenting with the Genous Bio-engineered R stent. The primary endpoint was the absence of stent thrombosis or any occlusion within three months.
› Verified 7 days ago
Kraig K Solak, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 150 7th Ave Ste 200, Chardon, OH 44024 Phone: 440-285-4999 Fax: 440-285-5870 | |
Albert S Dunn, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 150 7th Ave Ste 200, Chardon, OH 44024 Phone: 440-285-4999 Fax: 440-285-5870 | |
George J Kellis, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 150 7th Ave Ste 200, Chardon, OH 44024 Phone: 440-285-4999 Fax: 440-285-5870 | |
Scott M Zimmer, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 13170 Ravenna Road, Suite 200, Chardon, OH 44024 Phone: 844-542-6363 Fax: 440-279-1582 | |
Laszlo S Harmat, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 150 7th Ave Ste 200, Chardon, OH 44024 Phone: 440-285-4999 Fax: 440-285-5870 | |
Jonathan Benjamin Macknin, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 13207 Ravenna Rd, Chardon, OH 44024 Phone: 440-285-5004 Fax: 440-285-6985 |